Preliminary data from researchers in China suggest the NB.1.8.1 variant is not better at evading the immune system compared ...

The mRNA vaccines were developed using novel technology that was approved for the first time for public use during the COVID-19 pandemic.

The FDA has updated COVID-19 vaccine regulations. Only people aged 65 and up, along with certain groups, will be eligible to receive booster shots. FDA officials are asking for more data around the ...

The FDA has told vaccine manufacturers to expand the warning labels on their COVID-19 shots with more information about the ...

On May 20, 2025, the Food and Drug Administration announced a new stance on who should receive the COVID-19 vaccine.

Trump administration to restrict COVID vaccines to seniors and high-risk groups, pending more data for everyone else.

Government advisers are convening to discuss potential COVID-19 vaccine updates for the fall and winter, amidst a new policy that limits routine boosters to seniors and high-risk individuals. The FDA ...

FDA now requires Pfizer and Moderna COVID-19 vaccines to carry expanded warning labels about risks of myocarditis and pericarditis ...

Government vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winter ...

The FDA may limit annual COVID-19 boosters to high-risk groups unless clinical trials prove benefits for healthy adults under 65. Pfizer is reviewing the plan, while officials call for more evidence ...

The vaccine advisory committee for the Food and Drug Administration met Thursday to discuss potential changes to the formula for COVID-19 vaccines for 2025-2026.